# Beatriz Dietl

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/beatriz-dietl/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,494 |
| Field | COVID-19 Clinical Research Studies |
| h-index | 12 |
| i10-index | 18 |
| OpenAlex ID | https://openalex.org/A5083983422 |
| ORCID iD | 0000-0001-6011-6986 |
| Works | 41 |

## Researcher papers

- [Whole-genome sequencing reveals host factors underlying critical COVID-19](https://scholariq.org/papers/whole-genome-sequencing-reveals-host-factors-underlying-critical-covid-19/)
- [GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19](https://scholariq.org/papers/gwas-and-meta-analysis-identifies-49-genetic-variants-underlying-critical-covid/)
- [A first update on mapping the human genetic architecture of COVID-19](https://scholariq.org/papers/a-first-update-on-mapping-the-human-genetic-architecture-of-covid-19/)
- [Epigenome-wide association study of COVID-19 severity with respiratory failure](https://scholariq.org/papers/epigenome-wide-association-study-of-covid-19-severity-with-respiratory-failure/)
- [Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)](https://scholariq.org/papers/treatment-with-tocilizumab-or-corticosteroids-for-covid-19-patients-with/)
- [A second update on mapping the human genetic architecture of COVID-19](https://scholariq.org/papers/a-second-update-on-mapping-the-human-genetic-architecture-of-covid-19/)
- [SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues](https://scholariq.org/papers/sars-cov-2-susceptibility-and-covid-19-disease-severity-are-associated-with/)
- [Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial](https://scholariq.org/papers/cloxacillin-plus-fosfomycin-versus-cloxacillin-alone-for-methicillin-susceptible/)
- [Ceftolozane/tazobactam in the treatment of osteomyelitis and skin and soft-tissue infections due to extensively drug-resistant Pseudomonas aeruginosa : clinical and microbiological outcomes](https://scholariq.org/papers/ceftolozane-tazobactam-in-the-treatment-of-osteomyelitis-and-skin-and-soft/)
- [Update on the Role of Ceftazidime-Avibactam in the Management of Carbapenemase-Producing Enterobacterales](https://scholariq.org/papers/update-on-the-role-of-ceftazidime-avibactam-in-the-management-of-carbapenemase/)
- [Very Early Transition to Oral Antibiotics in Uncomplicated Enterobacterales Bloodstream Infections: Effectiveness and Impact on Carbon Footprint Saving](https://scholariq.org/papers/very-early-transition-to-oral-antibiotics-in-uncomplicated-enterobacterales/)

## Researcher topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Antibiotic Use and Resistance](https://scholariq.org/topics/antibiotic-use-and-resistance/)
- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)
- [Pneumonia and Respiratory Infections](https://scholariq.org/topics/pneumonia-and-respiratory-infections/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.